Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis

Cancer Science

Volumn 105, Issue 5, 2014, Pages 608-615

  Takata, Katsuyoshi ^a   Tanino, Motohiko ^b   Ennishi, Daisuke ^c,d   Tari, Akira ^e   Sato, Yasuharu ^a   Okada, Hiroyuki ^a   Maeda, Yoshinobu ^d   Goto, Naoe ^f   Araki, Hiroshi ^g   Harada, Mai ^a   Ando, Midori ^a   Iwamuro, Masaya ^a   Tanimoto, Mitsune ^d   Yamamoto, Kazuhide ^a   Gascoyne, Randy D ^c   Yoshino, Tadashi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b DNA CHIP RESEARCH INC   (Japan)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d OKAYAMA UNIVERSITY   (Japan)

^e ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^f GIFU UNIVERSITY   (Japan)

^g GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

CCL20; Duodenal follicular lymphoma; Gene expression profile; MAdCAM 1; MALT lymphoma

Indexed keywords

CADHERIN; CANNABINOID 2 RECEPTOR; CHEMOKINE RECEPTOR CCR6; CLAUDIN 3; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DISCOIDIN DOMAIN RECEPTOR TYROSINE KINASE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCAGON RECEPTOR; GLUTATHIONE PEROXIDASE 3; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INTERFERON; INTERFERON ALPHA INDUCIBLE PROTEIN 6; INTERFERON INDUCED PROTEIN 44; INTERLEUKIN 21; LIPOPROTEIN LIPASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; OLFACTORY RECEPTOR FAMILY 2; PHOSPHOLIPASE A2 RECEPTOR; PLASMINOGEN ACTIVATOR; PROTEIN TYROSINE KINASE; PROTOCADHERIN GAMMA; RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RHO GTPASE ACTIVATING PROTEIN 17; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; DUODENAL FOLLICULAR LYMPHOMA; DUODENUM CARCINOMA; DUODENUM MUCOSA; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPHOID HYPERPLASIA; MAJOR CLINICAL STUDY; MARGINAL ZONE LYMPHOMA; MESENTERY LYMPH NODE; MICROARRAY ANALYSIS; MULTIGENE FAMILY; NODAL FOLLICULAR LYMPHOMA; NODAL MARGINAL ZONE LYMPHOMA; OLFACTORY RECEPTOR; PARAAORTIC LYMPH NODE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REACTIVE LYMPHOID HYPERPLASIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STOMACH MUCOSA; T LYMPHOCYTE ACTIVATION; UPREGULATION;

CCL20; DUODENAL FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILE; MADCAM-1; MALT LYMPHOMA;

CADHERINS; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CCL20; DENDRITIC CELLS; DOWN-REGULATION; DUODENAL NEOPLASMS; DUODENUM; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, FOLLICULAR; MOLECULAR SEQUENCE DATA; MUCOPROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CCR6; UP-REGULATION;

EID: 84899924823     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12392     Document Type: Article

References (33)

1. Harris NL, Swerdlow SH, Jaffe ES et al. Follicular lymphoma. In: Harris NL, Swerdlow SH, Jaffe ES, Ott G, Nathwani BN, de Jong D, Yoshino T, Spagnolo D, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Lyon: IARC, 2008; 220-6.
2. Yoshino T, Miyake K, Ichimura K et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol 2000; 24: 688-93.
3. Takata K, Sato Y, Nakamura N et al. Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations. Mod Pathol 2009; 22: 940-9.
4. Takata K, Okada H, Ohmiya N et al. Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan. Cancer Sci 2011; 102: 1532-6.
5. Takata K, Sato Y, Nakamura N et al. Follicular lymphoma lacks AID but express BACH2 and has memory B cell characteristics. Mod Pathol 2013; 26: 22-31.
6. Shia J, Teruya-Feldstein J, Pan D et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol 2002; 26: 216-24.
7. Relander T, Johnson NA, Farinha P, Connors JM, Sehn LH, Gascoyne RD. Prognostic factors in follicular lymphoma. J Clin Oncol 2010; 28: 2902-13.
8. Johansson B, Mertens F, Mielman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 1995; 86: 3905-14.
9. Glas AM, Knoops L, Delahaye L et al. Gene expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007; 25: 390-8.
10. Arribas AJ, Martin YC, Abad CG et al. Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets. Blood 2012; 119: e9-21.
11. Glas AM, Kersten MJ, Delahaye LJ et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 2005; 105: 301-7.
12. O'Rourke JL. Gene expression profiling in Helicobacter-induced MALT lymphoma with reference to antigen drive and protective immunization. J Gastroenterol Hepatol 2008; 23: S151-6.
13. Rohatiner A, d'Amore F, Coiffier B et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
14. Saeed AI, Sharov V, White J et al. TM4: a free open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374-8.
15. Durig J, Schmuker U, Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia 2001; 15: 752-6.
16. Bell D, Chomarat P, Broyles D et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999; 190: 1417-26.
17. Kimura T, Takeshima H, Nomiyama N et al. Expression of lymphocyte-specific chemokines in human malignant glioma: essential role of LARK in cellular immunity of malignant glioma. Int J Oncol 2002; 21: 707-15.
18. Kleff J, Kusama T, Rossi DL et al. Detection and localization of MIP-3α/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999; 81: 650-7.
19. Scarpino S, Stoppaciaro A, Ballerini F et al. Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells. Am J Pathol 2000; 156: 831-7.
20. Shimizu Y, Murata H, Kashii Y et al. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3α might be involved in the amplification of local necroinflammatory response in the liver. Hepatology 2001; 34: 311-9.
21. Graves DR, Wang W, Dairaghi DJ et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J Exp Med 1997; 186: 837-44.
22. Baba M, Imai T, Nishimura M et al. Identification of CCR6, the specific receptor for the CC chemokine LARC. J Biol Chem 1997; 272: 14893-8.
23. Iwasaki A, Kelsall BL. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J Exp Med 2000; 17: 1381-93.
24. Schmats AI, Streubel B, Kretschmer-Chott E et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol 2011; 29: 1445-51.
25. Esplugues E, Huber S, Gagliani N et al. Control of TH17 cells occurs in the small intestine. Nature 2011; 475: 514-8.
26. Liu YX, Yoshino T, Ohara N et al. Loss of expression of α4β7 integrin and L-selection is associated with high-grade progression of low-grade MALT lymphoma. Mod Pathol 2001; 14: 798-805.
27. Bende RJ, Smit LA, Bossenbroek JG et al. Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 2003; 162: 105-13.
28. Chen WV, Alvarez FJ, Lefebvre JL et al. Funtional significance of isoform diversification in the protocadherin gamma gene cluster. Neuron 2012; 75: 402-9.
29. Imoto I, Izumi H, Yokoi S et al. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res 2006; 66: 4617-26.
30. Novak P, Jansen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res 2008; 68: 8616-25.
31. Dallosso AR, Hancock AL, Szemes M et al. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor. PLoS Genet 2009; 5: e1000745.
32. Dallosso AR, Oster B, Greenhough A et al. Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene 2012; 31: 4409-19.
33. Yang Y, Liu J, Li X, Li JC. PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer. Histol Histopathol 2012; 27: 217-24.